Dr Lars Brzoska

At Jungheinrich’s Annual General Meeting on 11 March the company reported on a challenging but, very successful 2022 financial year. A dividend of 0.68 euro per preferred share and 0.66 euro per ordinary share was proposed. Chairman of the board of management Dr Lars Brzoska looked back on the successful 2022 financial year – a […]

Jungheinrich is paying its employees worldwide a Covid bonus this year. With this special payment, Jungheinrich thanks its employees for their outstanding performance during the coronavirus crisis and acknowledges the additional burden placed on the workforce by the pandemic. Dr Lars Brzoska, chairman of the board of management of Jungheinrich AG said, “The coronavirus pandemic […]

At the end of the 2019 financial year, Jungheinrich had generated revenue of more than €4 billion. As a result, the company achieved its strategic growth target for 2020 a year earlier than planned. Incoming orders amounted to €3.92 billion, EBIT came to €263 million and EBIT return on sales amounted to 6.4%. Demand for […]